39 related articles for article (PubMed ID: 21112251)
21. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
Dietrich J; Doherty TM
APMIS; 2009 May; 117(5-6):440-57. PubMed ID: 19400867
[TBL] [Abstract][Full Text] [Related]
22. [Therapy in tuberculosis].
Somoskövi A; Lantos A
Orv Hetil; 2004 Apr; 145(16):871-3. PubMed ID: 15156693
[No Abstract] [Full Text] [Related]
23. Present and new drug regimens in chemotherapy and chemoprophylaxis of tuberculosis.
Grosset J
Bull Int Union Tuberc Lung Dis; 1990; 65(2-3):86-91. PubMed ID: 2257371
[No Abstract] [Full Text] [Related]
24. [Anti-tuberculosis drugs].
Doi N
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():367-74. PubMed ID: 17455647
[No Abstract] [Full Text] [Related]
25. [Short and intermittent treatment in tuberculosis].
Zapatero Domínguez J; Zapatero Gaviria J; Zapatero Gaviria A
Rev Clin Esp; 1980 Dec; 159(6):439-50. PubMed ID: 7012963
[No Abstract] [Full Text] [Related]
26. Anti-tuberculosis regimens of chemotherapy. Recommendations from the Committee on Treatment of the International Union against Tuberculosis and Lung Disease.
Girling DJ; Caulet P; Pamra SP; Pilheu JA
Indian J Chest Dis Allied Sci; 1988; 30(4):296-304. PubMed ID: 3076583
[No Abstract] [Full Text] [Related]
27. [Therapy of tuberculosis].
Eier A; Grass S
Wien Med Wochenschr; 1994; 144(8-9):186-8. PubMed ID: 7941607
[TBL] [Abstract][Full Text] [Related]
28. Tuberculosis chemotherapy, a review of current treatment regimens.
Teo SK
Singapore Med J; 1982 Feb; 23(1):55-60. PubMed ID: 7051331
[No Abstract] [Full Text] [Related]
29. Structure and function of the tuberculous lung: considerations for inhaled therapies.
Sethi T; Agrawal A
Tuberculosis (Edinb); 2011 Jan; 91(1):67-70. PubMed ID: 20947432
[TBL] [Abstract][Full Text] [Related]
30. Loss of oxyR in Mycobacterium tuberculosis.
Deretic V; Song J; Pagán-Ramos E
Trends Microbiol; 1997 Sep; 5(9):367-72. PubMed ID: 9294894
[TBL] [Abstract][Full Text] [Related]
31. Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
van Ingen J; Aarnoutse RE; Donald PR; Diacon AH; Dawson R; Plemper van Balen G; Gillespie SH; Boeree MJ
Clin Infect Dis; 2011 May; 52(9):e194-9. PubMed ID: 21467012
[TBL] [Abstract][Full Text] [Related]
32. Antitubercular inhaled therapy: opportunities, progress and challenges.
Pandey R; Khuller GK
J Antimicrob Chemother; 2005 Apr; 55(4):430-5. PubMed ID: 15761077
[TBL] [Abstract][Full Text] [Related]
33. New approaches to the treatment of latent tuberculosis.
Sterling TR
Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686
[TBL] [Abstract][Full Text] [Related]
34. Tuberculosis: a six-month cure.
Chaulet P
World Health Forum; 1989; 10(1):116-22. PubMed ID: 2665766
[TBL] [Abstract][Full Text] [Related]
35. Optimisation of inhaled tuberculosis therapies and implications for host-pathogen interactions.
Hickey AJ; Misra A; Robertson BD
Tuberculosis (Edinb); 2011 Jan; 91(1):64. PubMed ID: 21112251
[No Abstract] [Full Text] [Related]
36. Optimization of inhaled therapies for tuberculosis: the role of macrophages and dendritic cells.
González-Juarrero M; O'Sullivan MP
Tuberculosis (Edinb); 2011 Jan; 91(1):86-92. PubMed ID: 20888298
[TBL] [Abstract][Full Text] [Related]
37. Inhaled drug therapy for treatment of tuberculosis.
Misra A; Hickey AJ; Rossi C; Borchard G; Terada H; Makino K; Fourie PB; Colombo P
Tuberculosis (Edinb); 2011 Jan; 91(1):71-81. PubMed ID: 20875771
[TBL] [Abstract][Full Text] [Related]
38. The long and winding road to inhaled TB therapy: not only the bug's fault.
Giovagnoli S; Schoubben A; Ricci M
Drug Dev Ind Pharm; 2017 Mar; 43(3):347-363. PubMed ID: 27977937
[TBL] [Abstract][Full Text] [Related]
39. A philosophy of anti-infectives as a guide in the search for new drugs for tuberculosis.
Nathan C; Gold B; Lin G; Stegman M; de Carvalho LP; Vandal O; Venugopal A; Bryk R
Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S25-33. PubMed ID: 18762150
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
